ANDG vs BABA

The Advanced Deterministic Scorecard shows strong financial health with a Piotroski F-Score of 7/9, indicating robust fundamentals. Despite missing Altman Z-Score and key valuation metrics, the company exhibits solid profitability, low leverage, and strong revenue growth. However, stagnant price performance over multiple timeframes and lack of dividend commitment temper optimism. Analysts recommend a 'buy' with a target price of $29.50, implying upside potential, but weak insider activity and technical trend raise caution.

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.